Bunkerhill Health Raises $25M Series B for Carebricks
Bunkerhill Health raised a $25 million Series B led by Khosla Ventures, bringing total funding to $55 million. The company plans to expand Carebricks, its platform for deploying clinical, operational, and administrative AI agents inside health systems.
Bunkerhill Health has closed a $25 million Series B led by Khosla Ventures, bringing its total funding across seed, Series A, and Series B rounds to $55 million. Sequoia Capital, Felicis, Optum Ventures, and Y Combinator also participated, according to Fortune's exclusive report.
The company says the financing will expand Carebricks, a platform that helps health systems build and operate AI agents across clinical, operational, and administrative workflows.
What Carebricks is doing
Bunkerhill's announcement says Carebricks is deployed at Cleveland Clinic, the University of Texas Medical Branch, and Intermountain Health. The platform supports workflows ranging from reviewing cardiology images and finding patients who need follow-up care to prior authorization and registry management.
At UTMB, the company and health system report more than 20 live agents. Their stated results include cutting average nephrology specialist wait times by more than 50%, handling urgent lung-nodule findings 80% faster, and doubling guideline-concordant follow-up. Those figures come from Bunkerhill and UTMB rather than an independent clinical evaluation, so they are evidence of reported deployment outcomes, not proof that every implementation will reproduce them.
Fortune adds useful operating context: Bunkerhill works with 15 health systems and combines operational agents with nine FDA-cleared clinical AI algorithms. Fortune also reports that hospitals bring specific workflow problems to Bunkerhill rather than choosing only from a fixed catalog of vendor-defined use cases.
Why the funding matters
The round gives Bunkerhill more capital to expand implementation capacity and strengthen the governance, monitoring, and safeguards the company says health systems need for production deployments. The funding amount also requires a careful distinction: the Series B itself is $25 million; $55 million is the company's cumulative funding. Bunkerhill's own announcement emphasizes the total, while Fortune supplies the round amount.
For practitioners, the more durable signal is not the financing headline but the deployment model. Multi-agent healthcare systems must connect to existing clinical and administrative workflows, define escalation paths, monitor performance by site, and preserve human responsibility for care decisions. Reported outcomes at one institution are useful starting evidence, but health systems should validate safety, workload effects, and patient outcomes locally before expanding similar agents.
Key Points
- 1Bunkerhill Health raised a $25 million Series B led by Khosla Ventures, taking total funding to $55 million.
- 2The company and UTMB report more than 20 Carebricks agents operating across clinical, operational, and administrative workflows.
- 3Health systems evaluating similar platforms need local validation, monitoring, escalation paths, and clear human accountability.
Scoring Rationale
The $25 million round supports broader deployment of a healthcare agent platform with reported use across 15 systems, but the outcome claims remain company- and customer-reported and the financing is not an industry-wide shift.
Sources
Primary source and supporting public references used for this report.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Health & Insurance problems
